Concepedia

Ronald G. Tilton

RG

Statistics

Publications

102

Citations

10.5K

H-Index

54

Active since

1979

Affiliations

Washington University in St. Louis(Current)

The University of Texas Medical Branch at Galveston

Ghent University Hospital

Aarhus University

Aarhus University Hospital

Ronald G. Tilton is an author at Washington University in St. Louis specializing in medicine, diabetology, and diabetes mellitus.

ORCID

Publications per year

1979–2019

102

Publications

102

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

Thomas P. Misko, William M. Moore, Thomas P. Kasten et al. · European Journal of Pharmacology · 1993 · 727 citations

, , +6

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

John A. Corbett, Ronald G. Tilton, Kathy Chang et al. · Diabetes · 1992 · 611 citations · Full text

, , +16

An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice

Brian Tieu, Chang Lee, Hong Sun et al. · Journal of Clinical Investigation · 2009 · 455 citations · Full text

, , +17

Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes

An S. De Vriese, Ronald G. Tilton, Marlies Elger et al. · Journal of the American Society of Nephrology · 2001 · 445 citations

, , +17

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

Anne H. Cross, Thomas P. Misko, R F Lin et al. · Journal of Clinical Investigation · 1994 · 384 citations · Full text

, , +17

1–5 of 102